European Man May Be 6th Person to Be ‘Cured’ of HIV
THURSDAY, July 20, 2023 (HealthDay News) — It’s rare for someone with HIV to go into remission and be considered “cured,” but a European man may be the sixth to do so.First diagnosed with HIV in 1990, the man had been taking antiretroviral drugs sinc…
Learn MoreDurante la pandemia, los hogares de ancianos usaron menos fármacos para la COVID de lo previsto
MARTES, 18 de julio de 2023 (HealthDay News) — Aunque los residentes de los hogares de ancianos tienen un riesgo alto de malos resultados si contraen la COVID-19, el uso de tratamientos antivirales, como los anticuerpos monoclonales, fue bajo a lo la…
Learn MoreLa FDA aprueba un nuevo fármaco para proteger a los bebés del VSR
LUNES, 17 de julio de 2023 (HealthDay News) — Ahora, los padres cuentan con un nuevo medicamento de larga acción para proteger a sus hijos del virus sincitial respiratorio (VSR), un germen común que cada año envía a hasta un 3 por ciento de los niños…
Learn MoreCould Your Genes Guard You From the Symptoms of COVID Infection?
WEDNESDAY, July 19, 2023 (HealthDay News) — In the world of COVID-19 infections, the majority of patients develop symptoms, while about one-fifth mysteriously don’t develop a cough, sore throat or other tell-tale signs of illness.Now, new research fi…
Learn MoreNursing Homes Used COVID Meds Less Than Expected During Pandemic
TUESDAY, July 18, 2023 (HealthDay News) — While nursing home residents are at high risk for bad outcomes if they get COVID-19, use of antiviral treatments, such as monoclonal antibodies, was low through most of 2021 and 2022.The authors of a new stud…
Learn MoreFDA Approves New Drug to Protect Against RSV in Infants
MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common infection that hospitalizes as many as 3 percent of children younger than 1 year in the Unit…
Learn MoreFDA Approves New Drug to Protect Against RSV in Infants
MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States eac…
Learn MoreLa COVID redujo las probabilidades de embarazo de mujeres que recibían estimulación ovárica
VIERNES, 14 de julio de 2023 (HealthDay News) — Tener un resultado positivo en una prueba de la infección con la COVID-19 durante una fase particular del tratamiento para la fertilidad podría reducir las probabilidades de un embarazo exitoso, señala …
Learn MoreIndigenous Children Continue to Experience High Rates of RSV
FRIDAY, July 14, 2023 (HealthDay News) — American Indian/Alaska Native (AI/AN) children experience high rates of respiratory syncytial virus (RSV)-associated acute respiratory illness (ARI) hospitalization, according to a study published online July …
Learn MoreCOVID Infection in Women Having Ovary Stimulation Lowered Chances for Pregnancy
FRIDAY, July 14, 2023 (HealthDay News) — Testing positive for a COVID-19 infection during a particular phase of fertility treatment could reduce the odds for a successful pregnancy, a new study says.That phase of treatment is called controlled ovaria…
Learn More